“The results mark the first late-stage success for an oral antiviral used to prevent COVID-19 after exposure.
Original story
Continue reading at Japan Times Latest
www.japantimes.co.jp
Summary generated from the RSS feed of Japan Times Latest. All article rights belong to the original publisher. Click through to read the full piece on www.japantimes.co.jp.
